Fed. Circ. Snubs Patent Appeal Over Allergan Pinkeye Drug
The Federal Circuit on Monday rejected Allergan Inc.'s bid to revive its second infringement suit against Apotex Inc. over a patent for the pinkeye treatment Zymar, saying in a split decision...To view the full article, register now.
Already a subscriber? Click here to view full article